Adherium Share Price and Company Fundamentals



Price
$0.004
Change
0.000 (0.000%)
52 week range
0.003 - 0.012999

Last traded: Today at 4:02 AM

Adherium Limited, a digital health company, develops, manufactures, and supplies digital health technologies that address sub-optimal medication use in chronic diseases in New Zealand, Australia, Europe, and North America. The company offers Hailie Smartinhaler, a system for management of chronic respiratory conditions, including asthma and chronic obstructive pulmonary disease. It also provides Hailie Smartinhaler sensors; Hailie Solution; and Hailie Remote Patient Monitoring (RPM) Solution. The company was founded in 2001 and is based in Melbourne, Australia.

Key Metrics

PE ratio

-

PB ratio

-

Dividend yield

-

Beta

1.19

Market cap

$1.33M

Enterprise value

$10.53M

Company profile

Industry / Sector /
Website https://www.adherium.com
Mailing address 447 Collins Street Level 5 Melbourne VIC 3000 Australia
Phone / Fax 61 3 9415 4000 /

Dividends

More: Adherium Dividend history, yield and payout ratio

Dividend yield

-

Dividend amount

$-

Payout ratio

-

5Y Avg. yield

-%

Adherium paid $- dividend and the ex-dividend date was -.The dividend payout ratio is -. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.

Company Executives

As of Feb 2026, following are the company executives and directors listed on Adherium.

Name Title Age Total Pay
Ms. Emily Austin Company Secretary 39
Ms. Dawn Bitz Chief Executive Officer
Mr. Tom Quinlan Caretaker CFO
Ms. Julie Quinlan Head of People and Culture
Mr. Michael Motion Consultant
Mr. David Haddad Head of Product
Mr. Jason Hochman Head of US Commercial/GTM
Ms. Hetal Dhruve Head of Medical & Clinical Affairs
Ms. Catherine Morgan Head of Regulatory & Quality
Dr. John Douglas Wilson ChB, FRACP, FRCPA, MB, Ph.D. Executive Medical Director 88

Profitability and management effectiveness

Profit margin

0.00%

Operating margin

-2110.36%

Return on assets

-116.94%

Return on equity

-1476.80%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Adherium is 1.33M and its enterprise value is 10.53M. The enterprise value to revenue ratio of ADR is 12.88. The enterprise value to EBITDA ratio of ADR is -0.84.

The ADR's stocks Beta value is 1.19 making it 19% more volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.

Companies similar to Adherium (ADR)

Adherium (ASX:ADR) Frequently Asked Questions

1. What is Adherium's Stock Symbol?

Adherium trades on ASX under the ticker symbol "ADR".

2. What is Adherium's stock price today?

One share of ADR stock can currently be purchased for approximately $0.004.

3. How can I contact Adherium?

Adherium's mailing address is 447 Collins Street Level 5 Melbourne VIC 3000 Australia. The company can be reached via phone at 61 3 9415 4000.

4. What is Adherium's official website?

The official website of Adherium is https://www.adherium.com.